Nurse Navigator Perspective

Luz M. Morales, RN, BSN
Complex GI Nurse Navigator
Sarah Cannon at HCA Healthcare
Plantation, FL

Hepatocellular carcinoma (HCC) is largely regarded as an incurable disease; therefore, it is treated as a chronic ongoing condition. As oncology nurse navigators for patients with HCC, our role is to be a patient advocate and educate individuals on recommended treatments, as well as ensure that they have the necessary resources to continue with treatments and understand their choices. We have opportunities to bring the multidisciplinary team together to help patients throughout the continuum of care.

During initial diagnosis, patients are confused and unsure of which way to turn. Navigators are at the forefront of patient care and are the extra set of ears for patients’ questions, concerns, and needs. As we help them complete distress screenings, we get a clearer picture of anticipated needs and start the preparations necessary for patients to begin the treatment process.

In many instances, patients diagnosed with HCC have challenging backgrounds and lack support from family and friends, which makes compliance with treatment more difficult. It is important to establish a rapport with patients since this helps build trust and allows them the opportunity to reveal important aspects of their lives that might affect treatment success. For example, if patients are active alcoholics or intravenous drug users, these barriers must be addressed.

A team approach to patient care is extremely important. It is critical that patients are educated on the importance of being compliant with therapy and that they understand why they cannot miss treatments. Patients with financial issues may be unable to pay for transportation or medications, and should be educated on when to notify the navigator or healthcare team for assistance. Nurse navigators play a vital role in navigating these individuals through the continuum of care.

Related Articles
Identifying Best Practices and Gaps in Late-Stage Lung Cancer: From Diagnosis and Staging Through Survivorship and/or End of Life
Nancy Collar, RRT-NPS, AE-C, ACCS, Brooke O’Neill, MSN, RN, Kim Parham, BSN, RN, CN-BN, Shawn Perkins, BSN, RN, OCN, Amy Jo Pixley, MSN, RN, OCN, ONN-CG(T), Emily Gentry, BSN, RN, HON-ONN-CG, OCN
|
September 2022 Vol 13, No 9
In the United States, the second most commonly diagnosed cancer in both men and women is lung cancer, including both non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).
Identifying Best Practices and Gaps in Early-Stage Lung Cancer: From Screening and Early Detection Through Resectable Disease Treatment
Nancy Collar, RRT-NPS, AE-C, ACCS, Brooke O’Neill, MSN, RN, Kim Parham, BSN, RN, CN-BN, Shawn Perkins, BSN, RN, OCN, Amy Jo Pixley, MSN, RN, OCN, ONN-CG(T), Emily Gentry, BSN, RN, HON-ONN-CG, OCN
|
February 2022 Vol 13, No 2
The Role of Oncology Nurse Navigators in Hepatocellular Carcinoma Treatment
Best Practices in Patient Navigation – The Role of Oncology Nurse Navigators in Hepatocellular Carcinoma Treatment
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country